Breast cancer survivors must remain vigilant for recurrence signs, which can manifest locally, regionally, or distantly. New ...

While traditional induction therapy for newly diagnosed stage 2 myeloma often focuses on combinations of proteasome inhibitors, immunomodulatory drugs, and steroids, these newer immunotherapy classes ...

Breast cancer is the most common cancer in women, so it's vital to know the signs and symptoms to look out for - and how to ...

We speak to a nurse to find out about the signs and symptoms of breast cancer, plus how to conduct a breast self examination ...

(WYTV)- Researchers at the Cleveland Clinic have been looking at bone cancer in children and young adults. They’ve found a gene that will increase the risk of developing it. They analyzed genetic ...

Survival rates for children with multi-metastatic Ewing’s sarcoma — a kind of bone cancer which has spread to multiple parts of the body — are ‘dismal’, scientists say. The five-year survival rate for ...

Study in @PNASNews (bit.ly/4oK42vm) from @HopkinsMedicine @JHUPath shows in mice that two @US_FDA-approved pain drugs also inhibit nerve signaling/blood vessel formation in #Osteosarcomas & slow ...

Inhibrx Biosciences’ antibody ozekibart has notched a key phase 2 win in a rare bone cancer that currently has no approved treatments, prompting the San Diego biotech to plot a submission to the FDA ...

Oct 23 (Reuters) - Inhibrx Biosciences (INBX.O), opens new tab said on Thursday its experimental drug helped slow the progression of a rare and aggressive bone cancer in a mid-stage trial, sending its ...

Kids with a rare bone cancer might live longer if prescribed a drug that blocks blood supply to tumors, researchers say. The drug pazopanib (Votrient) extended the lives of a small group of kids with ...

Ewing sarcoma is one of the most common bone cancers seen in children, and if it spreads, it can be deadly. One study found that under a quarter of children with multi-metastatic Ewing sarcoma ...

THURSDAY, Oct. 23, 2025 (HealthDay News) — Kids with a rare bone cancer might live longer if prescribed a drug that blocks blood supply to tumors, researchers say. The drug pazopanib (Votrient) ...